tiprankstipranks
OpGen Inc. (OPGN)
:OPGN
Holding OPGN?
Track your performance easily

OpGen (OPGN) Stock Price & Analysis

596 Followers

OPGN Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

29.70%70.30%
29.70% Insiders
― Other Institutional Investors
70.30% Public Companies and
Individual Investors

OPGN FAQ

What was OpGen Inc.’s price range in the past 12 months?
OpGen Inc. lowest stock price was $0.53 and its highest was $9.89 in the past 12 months.
    What is OpGen Inc.’s market cap?
    OpGen Inc.’s market cap is $14.50M.
      When is OpGen Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were OpGen Inc.’s earnings last quarter?
      OpGen Inc. released its earnings results on Aug 08, 2024. The company reported -$1.176 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.176.
        Is OpGen Inc. overvalued?
        According to Wall Street analysts OpGen Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does OpGen Inc. pay dividends?
          OpGen Inc. does not currently pay dividends.
          What is OpGen Inc.’s EPS estimate?
          OpGen Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does OpGen Inc. have?
          OpGen Inc. has 10,068,111 shares outstanding.
            What happened to OpGen Inc.’s price movement after its last earnings report?
            OpGen Inc. reported an EPS of -$1.176 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -12.5%.
              Which hedge fund is a major shareholder of OpGen Inc.?
              Currently, no hedge funds are holding shares in OPGN
              ---

              Company Description

              OpGen Inc.

              OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It helps to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
              ---

              OPGN Earnings Call

              Q2 2023
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Aethlon Medical
              Applied DNA Sciences
              Qualigen Therapeutics
              Benitec Biopharma
              Verastem
              NovaBay Pharma
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis